BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 11689210)

  • 1. Recombinant proapoA-I(Lys107del) shows impaired lipid binding associated with reduced binding to plasma high density lipoprotein.
    Huang W; Matsunaga A; Li W; Han H; Hoang A; Kugi M; Koga T; Sviridov D; Fidge N; Sasaki J
    Atherosclerosis; 2001 Nov; 159(1):85-91. PubMed ID: 11689210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single amino acid deletion in the carboxy terminal of apolipoprotein A-I impairs lipid binding and cellular interaction.
    Huang W; Sasaki J; Matsunaga A; Han H; Li W; Koga T; Kugi M; Ando S; Arakawa K
    Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):210-6. PubMed ID: 10634820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High level secretion of wild-type and mutant forms of human proapoA-I using baculovirus-mediated Sf-9 cell expression.
    Sorci-Thomas MG; Parks JS; Kearns MW; Pate GN; Zhang C; Thomas MJ
    J Lipid Res; 1996 Mar; 37(3):673-83. PubMed ID: 8728328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion of the propeptide of apolipoprotein A-I reduces protein expression but stimulates effective conversion of prebeta-high density lipoprotein to alpha-high density lipoprotein.
    Sviridov D; Pyle LE; Jauhiainen M; Ehnholm C; Fidge NH
    J Lipid Res; 2000 Nov; 41(11):1872-82. PubMed ID: 11060357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High yield overexpression and characterization of human recombinant proapolipoprotein A-I.
    McGuire KA; Davidson WS; Jonas A
    J Lipid Res; 1996 Jul; 37(7):1519-28. PubMed ID: 8827524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of individual amino acids of apolipoprotein A-I in the activation of lecithin:cholesterol acyltransferase and in HDL rearrangements.
    Cho KH; Durbin DM; Jonas A
    J Lipid Res; 2001 Mar; 42(3):379-89. PubMed ID: 11254750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The carboxyl-terminal hydrophobic residues of apolipoprotein A-I affect its rate of phospholipid binding and its association with high density lipoprotein.
    Laccotripe M; Makrides SC; Jonas A; Zannis VI
    J Biol Chem; 1997 Jul; 272(28):17511-22. PubMed ID: 9211897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein A-I (R151C)Paris is defective in activation of lecithin: cholesterol acyltransferase but not in initial lipid binding, formation of reconstituted lipoproteins, or promotion of cholesterol efflux.
    Daum U; Langer C; Duverger N; Emmanuel F; Benoit P; Denèfle P; Chirazi A; Cullen P; Pritchard PH; Bruckert E; Assmann G; von Eckardstein A
    J Mol Med (Berl); 1999 Aug; 77(8):614-22. PubMed ID: 10543393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid-free apolipoproteins A-I and A-II promote remodeling of reconstituted high density lipoproteins and alter their reactivity with lecithin:cholesterol acyltransferase.
    Durbin DM; Jonas A
    J Lipid Res; 1999 Dec; 40(12):2293-302. PubMed ID: 10588955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein A-IFIN (Leu159-->Arg) mutation affects lecithin cholesterol acyltransferase activation and subclass distribution of HDL but not cholesterol efflux from fibroblasts.
    Miettinen HE; Jauhiainen M; Gylling H; Ehnholm S; Palomäki A; Miettinen TA; Kontula K
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3021-32. PubMed ID: 9409289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural and functional properties of reconstituted high density lipoprotein discs prepared with six apolipoprotein A-I variants.
    Jonas A; von Eckardstein A; Kézdy KE; Steinmetz A; Assmann G
    J Lipid Res; 1991 Jan; 32(1):97-106. PubMed ID: 1901346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel mutant, ApoA-I nichinan (Glu235-->0), is associated with low HDL cholesterol levels and decreased cholesterol efflux from cells.
    Han H; Sasaki J; Matsunaga A; Hakamata H; Huang W; Ageta M; Taguchi T; Koga T; Kugi M; Horiuchi S; Arakawa K
    Arterioscler Thromb Vasc Biol; 1999 Jun; 19(6):1447-55. PubMed ID: 10364075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substitutions of glutamate 110 and 111 in the middle helix 4 of human apolipoprotein A-I (apoA-I) by alanine affect the structure and in vitro functions of apoA-I and induce severe hypertriglyceridemia in apoA-I-deficient mice.
    Chroni A; Kan HY; Kypreos KE; Gorshkova IN; Shkodrani A; Zannis VI
    Biochemistry; 2004 Aug; 43(32):10442-57. PubMed ID: 15301543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple dysfunctions of two apolipoprotein A-I variants, apoA-I(R160L)Oslo and apoA-I(P165R), that are associated with hypoalphalipoproteinemia in heterozygous carriers.
    Daum U; Leren TP; Langer C; Chirazi A; Cullen P; Pritchard PH; Assmann G; von Eckardstein A
    J Lipid Res; 1999 Mar; 40(3):486-94. PubMed ID: 10064737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naturally occurring and bioengineered apoA-I mutations that inhibit the conversion of discoidal to spherical HDL: the abnormal HDL phenotypes can be corrected by treatment with LCAT.
    Koukos G; Chroni A; Duka A; Kardassis D; Zannis VI
    Biochem J; 2007 Aug; 406(1):167-74. PubMed ID: 17506726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surface plasmon resonance biosensor studies of human wild-type and mutant lecithin cholesterol acyltransferase interactions with lipoproteins.
    Jin L; Shieh JJ; Grabbe E; Adimoolam S; Durbin D; Jonas A
    Biochemistry; 1999 Nov; 38(47):15659-65. PubMed ID: 10569952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of central alpha-helices of human apolipoprotein A-I in the maturation of high-density lipoproteins.
    Frank PG; N'Guyen D; Franklin V; Neville T; Desforges M; Rassart E; Sparks DL; Marcel YL
    Biochemistry; 1998 Sep; 37(39):13902-9. PubMed ID: 9753480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of apolipoprotein A-I lipidation on the formation and function of pre-beta and alpha-migrating LpA-I particles.
    Sparks DL; Frank PG; Braschi S; Neville TA; Marcel YL
    Biochemistry; 1999 Feb; 38(6):1727-35. PubMed ID: 10026251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of reconstituted high density lipoprotein discs containing human apolipoprotein A-I (ApoA-I) variants with murine adipocytes and macrophages. Evidence for reduced cholesterol efflux promotion by apoA-I(Pro165-->Arg).
    von Eckardstein A; Castro G; Wybranska I; Theret N; Duchateau P; Duverger N; Fruchart JC; Ailhaud G; Assmann G
    J Biol Chem; 1993 Feb; 268(4):2616-22. PubMed ID: 8428938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of apolipoprotein A-II on the structure and function of apolipoprotein A-I in a homogeneous reconstituted high density lipoprotein particle.
    Durbin DM; Jonas A
    J Biol Chem; 1997 Dec; 272(50):31333-9. PubMed ID: 9395462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.